Seeking Alpha

CV Therapeutics Inc. (CVTX)

()

News & PR
Market Currents

Buzz
Twitter: CVTX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

'When There's Blood in the Streets', Buy Biotech Stocks
Oct 10, 2008 • Ohad Hammer • ALNY, ALTH, AMGN • 13 Comments
Big Mergers Could Mean Sweet Gains for Biotech
Mar 13 • Smart Profits Report • AMGN, BBH, BIIB • 6 Comments
Screening for Potential Buyout Targets
Jun 5, 2007 • Mark Hines • AMR, ARUN, BE • 5 Comments
Know Your Options When Investing in Biotech Stocks
Mar 2 • Zacks.com • AMAG, ARNA, CVTX • 5 Comments
Looking for the Biotech Breakout
Jan 19 • Jeff Pierce • ANDS, BIIB, BMRN • 5 Comments
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2 • Mark Cifra • ACOR, ARNA, CVTX • 5 Comments
Ugly Stock Stats from an Ugly Bear
Feb 25 • Bespoke Investment Group • CVTX, EBS, IDIX • 4 Comments
Cramer's Mad Money - Unsafe at Any Yield (3/12/09)
Mar 13 • SA Editor Miriam Metzinger • AA, BAC, BBT • 4 Comments
Health Care Trends Part 2: M&A, Generic Competition, CROs
Jun 7 • Bullish Bankers • CVD, CVTX, GILD • 4 Comments
Eton Park Loads Up on Options
Sep 2 • Market Folly • AA, AGN, CAT • 3 Comments
New Emerging Biotech and Pharma Company Index
Nov 23, 2008 • Mike Havrilla • BMRN, CVTX, DNDN • 3 Comments
Will MERLIN Work Magic For CV Therapeutics?
Feb 6, 2007 • Jason Shade • CVTX • 2 Comments
71 Stocks Leading the Nasdaq Higher
Feb 13 • TraderMark • ADVS, AKAM, AMZN • 2 Comments
Jim Cramer's Mad Money Lightning Round Picks, 7/24/07
Jul 25, 2007 • SA Editor Miriam Metzinger • CELG, CVTX, DISCA • 2 Comments
Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
Nov 10, 2008 • Ohad Hammer • ABT, AGN, AMGN • 2 Comments
Where Might Genentech Investors Redeploy $47B?
Mar 16 • Michael Becker • ACOR, ALXN, AMAG • 2 Comments
Cramer's Lightning Round - So Sohu Me (3/26/09)
Mar 27 • SA Editor Miriam Metzinger • AGU, CAT, CVTX • 2 Comments
Biotech Bloodletting: CV Therapeutics and Vertex Pharmaceuticals (CVTX, VRTX)
Apr 26, 2006 • Travis Johnson • CVTX, VRTX • 1 Comment
Bullish Thesis for Biotech Remains Intact
Feb 5 • Michael Becker • ALPMF.PK, ANDS, BMRN • 1 Comment
Manikay Partners Buy Healthcare, Dump Financials
Aug 10 • Todd Walker • AHL, CVTX, GS • 1 Comment
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
May 9, 2008 • Don Dion • ABI, ALXN, CVTX • 1 Comment
Thursday's Options Recap
Mar 12 • Frederic Ruffy • AKS, AMR, CAL • 1 Comment
Thursday Options Update: LVS, CSCO, NWS, CVTX, BAC & WMT
Nov 6, 2008 • Andrew Wilkinson • BAC, CSCO, CVTX • 1 Comment
Wednesday Options Update: UTX, GE, USB, WMT, NTRS, BK & CVTX
Jan 21 • Andrew Wilkinson • BK, CVTX, GE • 1 Comment

CV Therapeutics Inc. (CVTX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers